Humacyte, Inc. (HUMA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $50.50M | +12.4% |
| 2024 | $44.94M | -44.1% |
| 2023 | $80.45M | -46.3% |
| 2022 | $149.77M | -31.1% |
| 2021 | $217.50M | +444.7% |
| 2020 | $39.93M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $50.50M | +12.4% |
| 2024 | $44.94M | -44.1% |
| 2023 | $80.45M | -46.3% |
| 2022 | $149.77M | -31.1% |
| 2021 | $217.50M | +444.7% |
| 2020 | $39.93M | — |